136 related articles for article (PubMed ID: 12593920)
1. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
He L; Chang HX; Chou TC; Savaraj N; Cheng CC
Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
[TBL] [Abstract][Full Text] [Related]
2. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.
Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
[TBL] [Abstract][Full Text] [Related]
6. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives.
Helissey P; Parrot-Lopez H; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963
[No Abstract] [Full Text] [Related]
7. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
[TBL] [Abstract][Full Text] [Related]
8. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
9. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents.
Lee H; Jeong I; Yang SI
Arch Pharm Res; 2002 Aug; 25(4):416-20. PubMed ID: 12214847
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
Helissey P; Cros S; Giorgi-Renault S
Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
17. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
Helissey P; Giorgi-Renault S; Renault J; Cros S
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
